Addressing a major transfusion safety issue, as of March 2004, AABB statute 5.1.5.1 mandates testing of all platelet units for bacterial contamination. The only commercially available tests for this purpose in the U.S. are culture-based tests which require 48-72 hours to deliver a result. Such tests are useful only for apheresis platelet testing, but not for random donor platelets. Under prior Phase I and Phase II SBIR grants, applicants developed a 50-minute test for bacterial contamination of platelets capable of detecting both gram-positive and gram-negative species at concentrations down to 103 CFU/ml. The test has been converted into kit form. Its simple procedure and pre-measured single dose reagents are aimed at the needs of transfusion services and blood banks which constitute the principal market. Compared with culture tests performed in the blood bank at the time of platelet collection, from which results must be extrapolated at later times, the proposed test is intended for application to platelet units at the point of release. Current point-of-release test methods rely on pH or glucose reagent strips, which have been shown to be inaccurate and insensitive. This new, fast and accurate test will increase the safety of transfused platelets and reduce the risk of transfusion-associated sepsis due to bacterial contamination, the number one cause of morbidity and mortality in transfusions today. It is the first test of its kind which can be applied to both apheresis and random donor platelet units. The BacTxTM test is based on the detection of peptidoglycan as a universal component of bacterial cell walls in both gram-positive and gram-negative species. The principle technological innovations underlying the BacTxTM test include (1) the application of an ultrasensitive enzymatic detection chemistry which is triggered by peptidoglycan, (2) the development of a sensitive colorimetric indicator to facilitate visualization and measurement of assay results, and (3) means for capturing bacteria from platelet concentrates for detection while avoiding interference and inhibition from platelets or other blood components. The main purpose of this project is to carry out a clinical trial of the diagnostic test kit developed under the previous Phase II program, to be submitted for FDA approval. As a device intended for screening blood products used in transfusion, this kit requires clearance by the FDA Center for Biologics Evaluation and Research (CBER) before it can be marketed with clinical claims as an in vitro diagnostic device. The clinical trial design will validate the sensitivity of the test in detecting bacteria spiked at various levels into platelet units, the specificity of the test in control units, and its reproducibility and stability. Its performance will be compared against culture as gold standard.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR012553-11
Application #
7687506
Study Section
Special Emphasis Panel (ZRG1-SBIB-L (40))
Program Officer
Brazhnik, Olga
Project Start
2005-09-29
Project End
2010-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
11
Fiscal Year
2009
Total Cost
$901,873
Indirect Cost
Name
University of Utah
Department
Biomedical Engineering
Type
Schools of Engineering
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Burton, B M; Aras, K K; Good, W W et al. (2018) Image-based modeling of acute myocardial ischemia using experimentally derived ischemic zone source representations. J Electrocardiol 51:725-733
Tong, Xin; Edwards, John; Chen, Chun-Ming et al. (2016) View-Dependent Streamline Deformation and Exploration. IEEE Trans Vis Comput Graph 22:1788-801
Burton, Brett M; Tate, Jess D; Good, Wilson et al. (2016) The Role of Reduced Left Ventricular, Systolic Blood Volumes in ST Segment Potentials Overlying Diseased Tissue of the Ischemic Heart. Comput Cardiol (2010) 43:209-212
Erem, Burak; Martinez Orellana, Ramon; Hyde, Damon E et al. (2016) Extensions to a manifold learning framework for time-series analysis on dynamic manifolds in bioelectric signals. Phys Rev E 93:042218
Raj, Mukund; Mirzargar, Mahsa; Preston, J Samuel et al. (2016) Evaluating Shape Alignment via Ensemble Visualization. IEEE Comput Graph Appl 36:60-71
Gao, Yi; Zhu, Liangjia; Cates, Joshua et al. (2015) A Kalman Filtering Perspective for Multiatlas Segmentation. SIAM J Imaging Sci 8:1007-1029
Gillette, Karli; Tate, Jess; Kindall, Brianna et al. (2015) Generation of Combined-Modality Tetrahedral Meshes. Comput Cardiol (2010) 2015:953-956
Erem, B; Hyde, D E; Peters, J M et al. (2015) COMBINED DELAY AND GRAPH EMBEDDING OF EPILEPTIC DISCHARGES IN EEG REVEALS COMPLEX AND RECURRENT NONLINEAR DYNAMICS. Proc IEEE Int Symp Biomed Imaging 2015:347-350
Coll-Font, J; Erem, B; Štóví?ek, P et al. (2015) A STATISTICAL APPROACH TO INCORPORATE MULTIPLE ECG OR EEG RECORDINGS WITH ARTIFACTUAL VARIABILITY INTO INVERSE SOLUTIONS. Proc IEEE Int Symp Biomed Imaging 2015:1053-1056
Elhabian, Shireen; Gur, Yaniv; Vachet, Clement et al. (2014) Subject-Motion Correction in HARDI Acquisitions: Choices and Consequences. Front Neurol 5:240

Showing the most recent 10 out of 149 publications